226 related articles for article (PubMed ID: 10766763)
21. Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.
Aznarez I; Zielenski J; Rommens JM; Blencowe BJ; Tsui LC
J Med Genet; 2007 May; 44(5):341-6. PubMed ID: 17475917
[TBL] [Abstract][Full Text] [Related]
22. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathology of the CFTR locus in male infertility.
Claustres M
Reprod Biomed Online; 2005 Jan; 10(1):14-41. PubMed ID: 15705292
[TBL] [Abstract][Full Text] [Related]
24. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Zielenski J; Rozmahel R; Bozon D; Kerem B; Grzelczak Z; Riordan JR; Rommens J; Tsui LC
Genomics; 1991 May; 10(1):214-28. PubMed ID: 1710598
[TBL] [Abstract][Full Text] [Related]
25. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations.
Nissim-Rafinia M; Chiba-Falek O; Sharon G; Boss A; Kerem B
Hum Mol Genet; 2000 Jul; 9(12):1771-8. PubMed ID: 10915765
[TBL] [Abstract][Full Text] [Related]
26. Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels.
Delaney SJ; Rich DP; Thomson SA; Hargrave MR; Lovelock PK; Welsh MJ; Wainwright BJ
Nat Genet; 1993 Aug; 4(4):426-31. PubMed ID: 7691356
[TBL] [Abstract][Full Text] [Related]
27. Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA.
Sanz DJ; Hollywood JA; Scallan MF; Harrison PT
PLoS One; 2017; 12(9):e0184009. PubMed ID: 28863137
[TBL] [Abstract][Full Text] [Related]
28. In NF1, CFTR, PER3, CARS and SYT7, alternatively included exons show higher conservation of surrounding intron sequences than constitutive exons.
Kaufmann D; Kenner O; Nurnberg P; Vogel W; Bartelt B
Eur J Hum Genet; 2004 Feb; 12(2):139-49. PubMed ID: 14560314
[TBL] [Abstract][Full Text] [Related]
29. Absence of mutations in the interspecies conserved regions of the CFTR promoter region in cystic fibrosis (CF) and CF related patients.
Verlingue C; Vuillaumier S; Mercier B; Le Gac M; Elion J; Férec C; Denamur E
J Med Genet; 1998 Feb; 35(2):137-40. PubMed ID: 9507393
[TBL] [Abstract][Full Text] [Related]
30. Linkage disequilibrium between the M470V variant and the IVS8 polyT alleles of the CFTR gene in CBAVD.
de Meeus A; Guittard C; Desgeorges M; Carles S; Demaille J; Claustres M
J Med Genet; 1998 Jul; 35(7):594-6. PubMed ID: 9678705
[TBL] [Abstract][Full Text] [Related]
31. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.
Cuppens H; Lin W; Jaspers M; Costes B; Teng H; Vankeerberghen A; Jorissen M; Droogmans G; Reynaert I; Goossens M; Nilius B; Cassiman JJ
J Clin Invest; 1998 Jan; 101(2):487-96. PubMed ID: 9435322
[TBL] [Abstract][Full Text] [Related]
32. An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.
Fernandez Alanis E; Pinotti M; Dal Mas A; Balestra D; Cavallari N; Rogalska ME; Bernardi F; Pagani F
Hum Mol Genet; 2012 Jun; 21(11):2389-98. PubMed ID: 22362925
[TBL] [Abstract][Full Text] [Related]
33. An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.
Arrisi-Mercado P; Romano M; Muro AF; Baralle FE
J Biol Chem; 2004 Sep; 279(38):39331-9. PubMed ID: 15247216
[TBL] [Abstract][Full Text] [Related]
34. Mechanism-Based Personalized Medicine for Cystic Fibrosis by Suppressing Pseudo Exon Inclusion.
Shibata S; Ajiro M; Hagiwara M
Cell Chem Biol; 2020 Dec; 27(12):1472-1482.e6. PubMed ID: 32905759
[TBL] [Abstract][Full Text] [Related]
35. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.
Buratti E; Baralle FE
J Biol Chem; 2001 Sep; 276(39):36337-43. PubMed ID: 11470789
[TBL] [Abstract][Full Text] [Related]
36. Atypical 5' splice sites cause CFTR exon 9 to be vulnerable to skipping.
Hefferon TW; Broackes-Carter FC; Harris A; Cutting GR
Am J Hum Genet; 2002 Aug; 71(2):294-303. PubMed ID: 12068373
[TBL] [Abstract][Full Text] [Related]
37. Exon-skipping antisense oligonucleotides for cystic fibrosis therapy.
Kim YJ; Sivetz N; Layne J; Voss DM; Yang L; Zhang Q; Krainer AR
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35017301
[TBL] [Abstract][Full Text] [Related]
38. Multi-physiopathological consequences of the c.1392G>T CFTR mutation revealed by clinical and cellular investigations.
Farhat R; El-Seedy A; El-Moussaoui K; Pasquet MC; Adolphe C; Bieth E; Languepin J; Sermet-Gaudelus I; Kitzis A; Ladevèze V
Biochem Cell Biol; 2015 Feb; 93(1):28-37. PubMed ID: 25403292
[TBL] [Abstract][Full Text] [Related]
39. Skipping of exon 9 of human CFTR in YAC-transgenic mice.
Manson A; Huxley C
Genomics; 2001 Oct; 77(3):127-34. PubMed ID: 11597137
[TBL] [Abstract][Full Text] [Related]
40. Dinucleotide (CA/GT) repeat polymorphism in intron 17B of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Morral N; Girbau E; Zielenski J; Nunes V; Casals T; Tsui LC; Estivill X
Hum Genet; 1992 Jan; 88(3):356. PubMed ID: 1370810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
